Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on IT Press Releases.
Press releases published on April 27, 2025
AI Technology Unlocks New Avenues for Animation and Online Income: Autodraft AI Leads the Charge
EIN Presswire
·
April 27, 2025
AI Technology Unlocks New Avenues for Animation and Online Income: Autodraft AI Leads the Charge BENGALURU, KARNATAKA, INDIA, April 28, 2025 /EINPresswire.com/ -- As artificial intelligence continues to expand its role in creative industries, a new …
DeepInfinity DeepScribe AI Now Available in Microsoft Azure Marketplace
EIN Presswire
·
April 27, 2025
Now on Microsoft Azure: DeepInfinity.AI’s Healthcare AI solutions for scalable, reliable …
Y-mAbs Presents Translational Pharmacokinetics of CD38-SADA from Pretargeted RIT Platform at 2025 American Association for Cancer Research (AACR) Annual Meeting
GlobeNewswire
·
April 27, 2025
NEW YORK, April 27, 2025 (GLOBE NEWSWIRE) -- Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”) (Nasdaq: YMAB), a commercial-stage biopharmaceutical company focused on the development and commercialization of novel radioimmunotherapy and antibody-based …
Israeli startups to compete for $1M prize from Startup World Cup
EIN Presswire
·
April 27, 2025
Leading VCs and Global Corporations to gather at Axis Tel Aviv for the annual startup investment conference to prove resilience of Israeli venture ecosystem TEL AVIV, ISRAEL, April 27, 2025 /EINPresswire.com/ -- One promising Israeli startup will have …
Abpro and Celltrion Unveil Preclinical Data for ABP-102/CT-P72 at AACR 2025, Showcasing Potential Best-in-Class HER2 x CD3 T-Cell Engager
GlobeNewswire
·
April 27, 2025
Data suggest potential for superior tumor selectivity, potent efficacy, and improved safety profile Abpro and Celltrion have a strategic partnership for worldwide development and commercialization of ABP-102/CT-P72 HER2-positive cancers represent up to 30 …
Revolution Medicines Presents Initial Data from Zoldonrasib (RMC-9805) Study in Patients with KRAS G12D Mutant Non-Small Cell Lung Cancer at the 2025 AACR Annual Meeting
GlobeNewswire
·
April 27, 2025
REDWOOD CITY, Calif., April 27, 2025 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a late-stage clinical oncology company developing targeted therapies for patients with RAS-addicted cancers, today announced new clinical data for …
SpringWorks Therapeutics Announces Expected CHMP Opinion in Q2 2025 for Nirogacestat for the Treatment of Adults with Desmoid Tumors in the European Union
GlobeNewswire
·
April 27, 2025
STAMFORD, Conn., April 27, 2025 (GLOBE NEWSWIRE) -- SpringWorks Therapeutics, Inc. (Nasdaq: SWTX), a commercial-stage biopharmaceutical company focused on severe rare diseases and cancer, announced today that the Company anticipates the Committee for …
BDSLCCI Framework strengthens Small & Medium Enterprises with Enhanced Cybersecurity & Compliance: SME Research Insights
EIN Presswire
·
April 27, 2025
Foundational Research and Practical Implementation of the BDSLCCI Cybersecurity Framework to Strengthen Security and Compliance for Small and Medium Enterprises SAN DIEGO, CA, UNITED STATES, April 26, 2025 /EINPresswire.com/ -- Small and Medium …
UPDATE -- Relmada Therapeutics To Present NDV-01 Data at AUA2025
GlobeNewswire
·
April 27, 2025
CORAL GABLES, Fla., April 27, 2025 (GLOBE NEWSWIRE) -- Relmada Therapeutics, Inc. (Nasdaq: RLMD, “Relmada”, “the Company”), a clinical-stage biotechnology company, today announced the presentation of an abstract at the American Urology Association (AUA2025 …
2025 (Spring) Pharmaceutical Machinery Exposition Concludes Successfully
GlobeNewswire
·
April 27, 2025
BEIJING, April 27, 2025 (GLOBE NEWSWIRE) -- On April 25, 2025, the 66th (Spring 2025) National Pharmaceutical Machinery Exposition …